Advertisement
Screener

Mirum Pharmaceuticals, Inc. (MIRM) Graph

2.8 / 5 stars · 68/120 Roast Me

MIRM Revenue Flow

MIRM Graph summary

Mirum Pharmaceuticals, Inc. (MIRM). Quarter ended 2026-06-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How Mirum Pharmaceuticals, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.18B $0.22B$-0.04B$0.08B$-0.04B$0.02B$0.00B$-0.07B Revenue from contracts with customers, excluding assessed tax$0.18BDeclared revenue$0.18B Operating expenses$0.22BOperating income$-0.04BSelling, general and administrative$0.08BOther expense, net$0.02BPre-tax income$-0.07BIncome tax$0.00BNet income$-0.07B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B
Advertisement